<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is the most frequent <z:hpo ids='HP_0005115'>supraventricular arrhythmia</z:hpo> in our environment </plain></SENT>
<SENT sid="1" pm="."><plain>The incidence and prevalence of this disease increase with age and with the presence of concomitant <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e>; consequently, AF is frequently encountered in the field of internal medicine </plain></SENT>
<SENT sid="2" pm="."><plain>Elderly patients have a series of characteristics that lead to a high risk of thromboembolic complications and hemorrhagic events </plain></SENT>
<SENT sid="3" pm="."><plain>Internal medicine specialists should be trained in the global management of this disease, in order to correctly evaluate the risk of complications and take unusually difficult decisions </plain></SENT>
<SENT sid="4" pm="."><plain>The new oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> provide an interesting and promising alternative in the prevention of AF-related <z:hpo ids='HP_0001297'>stroke</z:hpo>, although there are several limitations to consider before prescribing these agents in this group of patients </plain></SENT>
</text></document>